Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Eli Lilly and Company BDR (LILY34)
Market Closed
12 Jun, 19:55
B3
All
(1)
BR
(1)
B3
Primary
R$
191.
50
-6.49
-3.2779%
R$
5.32T
Market Cap
104.2
P/E Ratio
0.05%
Div Yield
23,443
Volume
6.64
Eps
R$
197.99
Previous Close
Watching
Watch
Add Transaction
Day Range
191.5
198.44
Year Range
113
208.36
Want to track
LILY34
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Eli Lilly and Company BDR (LILY34) Statistics
Valuation metrics
Market Cap
5.32T
Enterprise value
874.66B
Trailing P/E (ttm)
34.12
Forward P/E
-
PEG ratio
0.2
Price/Sales (ttm)
58.24
Price/Book (mrq)
32.22
Enterprise Value/Revenue
2.47
Enterprise Value/EBITDA
4.93
Overview
Shares outstanding
893.5M
Float
889.35M
Shares short
-
% Held by insiders
-
% Held by institutions
0%
Average volume (10 days)
22.17K
Average volume (90 days)
15.21K
Price summary
52-Week low
113
52-Week high
208.36
Beta
0.48
50-Day moving average
161.13
200-Day moving average
162.27
Dividends and splits
Forward annual dividend rate
0.83
Forward annual dividend yield
0.0052%
Trailing annual dividend rate
0.78
Trailing annual dividend yield
0.0048%
5-Year annual dividend yield
0.81%
Payout ratio
0.15
Dividend Date
16 Mar 2026
Ex-Dividend Date
11 Feb 2026
Last split factor
15:1
Last split Date
21 Nov 2022
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.35%
Operating margin
0.49%
Operational effectiveness
Return on assets
0.21%
Return on equity
1.07%
Income Statement
Revenue (ttm)
354.16B
Revenue per share (ttm)
2.66
Quarterly revenue growth (yoy)
0.56%
Gross profit (ttm)
293.36B
EBITDA
40.32B
Net income to common (ttm)
123.91B
Diluted EPS (ttm)
4.61
Quarterly earnings growth (yoy)
1.68%
Balance Sheet
Total cash (mrq)
25.89B
Total cash per share (mrq)
5.92
Total debt (mrq)
212.6B
Total Debt/Equity (mrq)
139.01
Current ratio (mrq)
1.5%
Book value per share (mrq)
4.88
Cash Flow
Cash flow statement
100.39B
Levered free cash flow (LFCF)
44.89B